Upon SMARCB1 loss-of-function, this process is significantly impaired, resulting in the repression of key tumour suppressor and lineage-specific differentiation genes [246] (see Section BAF and Polycomb complex antagonism). The gene discussed is SMARCB1; the disease is neoplasm.